A citation-based method for searching scientific literature

R Gisli Jenkins, Bethany B Moore, Rachel C Chambers, Oliver Eickelberg, Melanie Königshoff, Martin Kolb, Geoffrey J Laurent, Carmel B Nanthakumar, Mitchell A Olman, Annie Pardo, Moises Selman, Dean Sheppard, Patricia J Sime, Andrew M Tager, Amanda L Tatler, Victor J Thannickal, Eric S White. Am J Respir Cell Mol Biol 2017
Times Cited: 119







List of co-cited articles
706 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
28

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
27

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
Antje Moeller, Kjetil Ask, David Warburton, Jack Gauldie, Martin Kolb. Int J Biochem Cell Biol 2008
557
23

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
20

Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis.
Jun Tashiro, Gustavo A Rubio, Andrew H Limper, Kurt Williams, Sharon J Elliot, Ioanna Ninou, Vassilis Aidinis, Argyrios Tzouvelekis, Marilyn K Glassberg. Front Med (Lausanne) 2017
83
20

Murine models of pulmonary fibrosis.
Bethany B Moore, Cory M Hogaboam. Am J Physiol Lung Cell Mol Physiol 2008
497
14

Animal models of fibrotic lung disease.
Bethany B Moore, William E Lawson, Tim D Oury, Thomas H Sisson, Krishnan Raghavendran, Cory M Hogaboam. Am J Respir Cell Mol Biol 2013
212
14

Idiopathic pulmonary fibrosis.
Luca Richeldi, Harold R Collard, Mark G Jones. Lancet 2017
473
13

Idiopathic pulmonary fibrosis.
Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
12

Idiopathic pulmonary fibrosis.
Fernando J Martinez, Harold R Collard, Annie Pardo, Ganesh Raghu, Luca Richeldi, Moises Selman, Jeffrey J Swigris, Hiroyuki Taniguchi, Athol U Wells. Nat Rev Dis Primers 2017
294
12

Simple method of estimating severity of pulmonary fibrosis on a numerical scale.
T Ashcroft, J M Simpson, V Timbrell. J Clin Pathol 1988
885
12

Standardized quantification of pulmonary fibrosis in histological samples.
Ralf-Harto Hübner, Wolfram Gitter, Nour Eddine El Mokhtari, Micaela Mathiak, Marcus Both, Hendrik Bolte, Sandra Freitag-Wolf, Burkhard Bewig. Biotechniques 2008
253
12

Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis.
Elizabeth F Redente, Kristen M Jacobsen, Joshua J Solomon, Abigail R Lara, Sarah Faubel, Rebecca C Keith, Peter M Henson, Gregory P Downey, David W H Riches. Am J Physiol Lung Cell Mol Physiol 2011
80
13

Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Lutz Wollin, Isabelle Maillet, Valérie Quesniaux, Alexander Holweg, Bernhard Ryffel. J Pharmacol Exp Ther 2014
295
11

Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
416
11

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.
John Hutchinson, Andrew Fogarty, Richard Hubbard, Tricia McKeever. Eur Respir J 2015
334
10

Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance.
Louise Hecker, Naomi J Logsdon, Deepali Kurundkar, Ashish Kurundkar, Karen Bernard, Thomas Hock, Eric Meldrum, Yan Y Sanders, Victor J Thannickal. Sci Transl Med 2014
372
9

The Bleomycin Model of Pulmonary Fibrosis.
Tianju Liu, Francina Gonzalez De Los Santos, Sem H Phan. Methods Mol Biol 2017
70
12

The importance of interventional timing in the bleomycin model of pulmonary fibrosis.
Philipp Kolb, Chandak Upagupta, Megan Vierhout, Ehab Ayaub, Pierre Simon Bellaye, Jack Gauldie, Chiko Shimbori, Mark Inman, Kjetil Ask, Martin R J Kolb. Eur Respir J 2020
17
52

Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF.
Paul F Mercer, Hannah V Woodcock, Jessica D Eley, Manuela Platé, Michal G Sulikowski, Pascal F Durrenberger, Linda Franklin, Carmel B Nanthakumar, Yim Man, Federica Genovese,[...]. Thorax 2016
101
8

Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs.
Neil C Henderson, Thomas D Arnold, Yoshio Katamura, Marilyn M Giacomini, Juan D Rodriguez, Joseph H McCarty, Antonella Pellicoro, Elisabeth Raschperger, Christer Betsholtz, Peter G Ruminski,[...]. Nat Med 2013
472
8

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
940
8

Use of animal models in IPF research.
R Carrington, S Jordan, S C Pitchford, C P Page. Pulm Pharmacol Ther 2018
31
25

Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation.
Adam J Booth, Ryan Hadley, Ashley M Cornett, Alyssa A Dreffs, Stephanie A Matthes, Jessica L Tsui, Kevin Weiss, Jeffrey C Horowitz, Vincent F Fiore, Thomas H Barker,[...]. Am J Respir Crit Care Med 2012
330
7

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Luca Richeldi, Ulrich Costabel, Moises Selman, Dong Soon Kim, David M Hansell, Andrew G Nicholson, Kevin K Brown, Kevin R Flaherty, Paul W Noble, Ganesh Raghu,[...]. N Engl J Med 2011
631
7

Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions.
Veronica Della Latta, A Cecchettini, S Del Ry, M A Morales. Pharmacol Res 2015
157
7

Time course of bleomycin-induced lung fibrosis.
G Izbicki, M J Segel, T G Christensen, M W Conner, R Breuer. Int J Exp Pathol 2002
241
7

The impact of TGF-β on lung fibrosis: from targeting to biomarkers.
Isis E Fernandez, Oliver Eickelberg. Proc Am Thorac Soc 2012
343
7

Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span.
Alexander V Misharin, Luisa Morales-Nebreda, Paul A Reyfman, Carla M Cuda, James M Walter, Alexandra C McQuattie-Pimentel, Ching-I Chen, Kishore R Anekalla, Nikita Joshi, Kinola J N Williams,[...]. J Exp Med 2017
353
7

Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
Brett Ley, Harold R Collard, Talmadge E King. Am J Respir Crit Care Med 2011
852
7

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
7

Optimising experimental research in respiratory diseases: an ERS statement.
Philippe Bonniaud, Aurélie Fabre, Nelly Frossard, Christophe Guignabert, Mark Inman, Wolfgang M Kuebler, Tania Maes, Wei Shi, Martin Stampfli, Stefan Uhlig,[...]. Eur Respir J 2018
50
14

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
7

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.
J S Munger, X Huang, H Kawakatsu, M J Griffiths, S L Dalton, J Wu, J F Pittet, N Kaminski, C Garat, M A Matthay,[...]. Cell 1999
6


Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.
Ana L Mora, Mauricio Rojas, Annie Pardo, Moises Selman. Nat Rev Drug Discov 2017
129
6

Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.
Fei Liu, David Lagares, Kyoung Moo Choi, Lauren Stopfer, Aleksandar Marinković, Vladimir Vrbanac, Clemens K Probst, Samantha E Hiemer, Thomas H Sisson, Jeffrey C Horowitz,[...]. Am J Physiol Lung Cell Mol Physiol 2015
338
6

Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix.
Pierre-Jean Wipff, Daniel B Rifkin, Jean-Jacques Meister, Boris Hinz. J Cell Biol 2007
826
6

Progress toward improving animal models for idiopathic pulmonary fibrosis.
Amber L Degryse, William E Lawson. Am J Med Sci 2011
86
6

Mechanisms of Lung Fibrosis Resolution.
Stephan W Glasser, James S Hagood, Simon Wong, Carmen A Taype, Satish K Madala, William D Hardie. Am J Pathol 2016
62
9

Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.
Marilyn K Glassberg, Julia Minkiewicz, Rebecca L Toonkel, Emmanuelle S Simonet, Gustavo A Rubio, Darcy DiFede, Shirin Shafazand, Aisha Khan, Marietsy V Pujol, Vincent F LaRussa,[...]. Chest 2017
107
6

Incidence and prevalence of idiopathic pulmonary fibrosis.
Ganesh Raghu, Derek Weycker, John Edelsberg, Williamson Z Bradford, Gerry Oster. Am J Respir Crit Care Med 2006
791
6


A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.
Yasmina Bauer, John Tedrow, Simon de Bernard, Magdalena Birker-Robaczewska, Kevin F Gibson, Brenda Juan Guardela, Patrick Hess, Axel Klenk, Kathleen O Lindell, Sylvie Poirey,[...]. Am J Respir Cell Mol Biol 2015
91
6

Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo.
Mareike Lehmann, Martina Korfei, Kathrin Mutze, Stephan Klee, Wioletta Skronska-Wasek, Hani N Alsafadi, Chiharu Ota, Rita Costa, Herbert B Schiller, Michael Lindner,[...]. Eur Respir J 2017
150
6

Cellular senescence mediates fibrotic pulmonary disease.
Marissa J Schafer, Thomas A White, Koji Iijima, Andrew J Haak, Giovanni Ligresti, Elizabeth J Atkinson, Ann L Oberg, Jodie Birch, Hanna Salmonowicz, Yi Zhu,[...]. Nat Commun 2017
499
6

Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease.
Ruoqi Peng, Sriram Sridhar, Gaurav Tyagi, Jonathan E Phillips, Rosario Garrido, Paul Harris, Lisa Burns, Lorena Renteria, John Woods, Leena Chen,[...]. PLoS One 2013
112
6

Macrophages in Tissue Repair, Regeneration, and Fibrosis.
Thomas A Wynn, Kevin M Vannella. Immunity 2016
6

Expression of mutant Sftpc in murine alveolar epithelia drives spontaneous lung fibrosis.
Shin-Ichi Nureki, Yaniv Tomer, Alessandro Venosa, Jeremy Katzen, Scott J Russo, Sarita Jamil, Matthew Barrett, Vivian Nguyen, Meghan Kopp, Surafel Mulugeta,[...]. J Clin Invest 2018
74
8

Idiopathic pulmonary fibrosis: pathogenesis and management.
Giacomo Sgalla, Bruno Iovene, Mariarosaria Calvello, Margherita Ori, Francesco Varone, Luca Richeldi. Respir Res 2018
128
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.